Three directors bought at total of 31,247 shares, for about $30,000. These represent the first insider purchases of 2007. Access Plans USA describes itself as “a nationwide distributor of health insurance and non-insurance healthcare programs that provide access to affordable healthcare for the growing number of uninsured and/or underinsured in the United States.” While it took a large loss last quarter mainly on a writedown of goodwill, revenues are growing and operating earnings are positive.

Insiders bought about 350,000 shares at $.70-$.80. Incentra, formerly Helio Solutions, is a provider of IT and storage management solutions to enterprises and managed service providers in North America and Europe. Incentra continues to lose money but has trimmed losses considerably. I especially like the increase in revenues — up 117 percent to $92.1 million for the first 9 months of the year. Sales dwarf the company’s tiny $17.48M market cap.. I think these insiders may be on to something, and I may join them.

The Frost Gamma Trust, an investment vehicle managed by the company’s CEO, Miami billionaire Dr. Phillip Frost, bought $20M in shares, bringing its holdings up to 62%. Opko is developing Bevasiranib, a small interfering RNA (siRNA) drug designed to silence the genes that produce vascular endothelial growth factor (VEGF), believed to be largely responsible for the vision loss of wet AMD. If anyone has a bead on the value of this drug, send me an email.

Imergent insiders continue to buy even as IIG stock plummets. Motley Fool named it the “worst stock,” and given the company’s miserable earnings report and continued legal woes, I’ll sit this one out.

Milton Berth, the CEO, President, and Chairman of this porn distribution company, continues to make large open-market purchases. Private Media has returned to profitability, but still trades at a high price-to-sales ratio.

Highland Capital continues to scoop up shares of TLC Vision, buying over a million shares last month. The laser vision correction chain lost a lot of money last quarter, mostly on impairment charges, but is cash flow positive.